Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
NICE's first guideline on kidney cancer recommends better use of biopsies to avoid surgery
KIM-1 emerges as a promising biomarker for renal cell carcinoma, enhancing prognosis and treatment decisions in kidney cancer management.
Ongoing studies in kidney cancer aim to explore determinants of immune-related adverse effects and strategies for mitigating them.
Belzutifan shows improved quality-adjusted survival in advanced renal cell carcinoma compared with everolimus, enhancing patient quality of life and treatment outcomes.
Panelists discuss how the CLEAR trial showed pembrolizumab plus lenvatinib achieved the highest objective response rate (71%) and progression-free survival (23.3 months) among frontline regimens, though requiring careful patient selection due to lenvatinib's challenging toxicity profile at the ...
Combination therapy of casdatifan and cabozantinib shows promising efficacy and manageable safety in advanced clear cell renal cell carcinoma patients.
Researchers explore the impact of CD163-positive tumor-associated macrophages on the effectiveness of nivolumab in treating metastatic clear cell renal cell carcinoma.
Panelists discuss how non–clear cell renal cell carcinoma (RCC) represents a challenging, heterogeneous collection of rare tumors comprising 25% to 30% of all RCC cases, requiring careful histological review and individualized risk stratification based on tumor biology, disease tempo, and ...
FDA approval of the selective HIF2α inhibitor belzutifan for advanced phaeochromocytoma and paraganglioma (PPGL) is an important milestone in precision oncology. This achievement underscores the power of scientific collaboration in establishing HIF2α as a central driver of PPGL pathogenesis ...
Panelists discuss how CheckMate 9ER results demonstrated significant progression-free survival and overall survival benefits with nivolumab plus cabozantinib vs sunitinib, with particularly impressive HRs for patients with visceral disease, including liver, bone, and lung metastases.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.